We discovered that rapamycin could rescue cell viability after OGD hypoxia and decrease the infarction volume after ischemia/reperfusion injury, prompting us to evaluate whether TDP-43-related pathology is involved in rapamycin’s therapeutic mechanism in ischemic stroke. This evidence concerns the gene TARDBP and ischemic stroke.